C07D 497/08
Bridged systems
C07D497/08 (Bridged systems) appears on 32 US grants and 14 published applications in this corpus.
Search patents in C07D- Granted patents
- 32
- Published applications
- 14
- Assignees
- 21
- Inventors
- 93
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 1 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Benzolactam compounds as protein kinase inhibitors16 Jun 2026US 12,655,137 B2Otsuka Pharmaceutical Co., Ltd.
- Benzolactam compounds as protein kinase inhibitors26 Mar 2024US 11,939,321 B2Otsuka Pharmaceutical Co., Ltd.
- Benzolactam compounds as protein kinase inhibitors11 May 2021US 11,001,575 B1Otsuka Pharmaceutical Co., Ltd.
- Benzolactam compounds as protein kinase inhibitors29 Oct 2019US 10,457,669 B2Otsuka Pharmaceutical Co., Ltd.
- Compound having perfluoroalkyl terminal group and CF2O bonding group, liquid crystal composition and liquid crystal display device17 Jan 2017US 9,546,181 B2Jnc Corporation
- Pyridinyl derivatives as sodium channel activators24 Apr 2025US 2025/0129044 A1Xenon Pharmaceuticals Inc.
- Benzolactam compounds as protein kinase inhibitors7 Nov 2024US 2024/0368136 A1Otsuka Pharmaceutical Co., Ltd.
- Pyridinyl derivatives as sodium channel activators18 May 2023US 2023/0150972 A1
- Benzolactam compounds as protein kinase inhibitors19 Jan 2023US 2023/0019032 A1Otsuka Pharmaceutical Co., Ltd.
- Chemically amplified positive-type photosensitive resin composition, photosensitive dry film, production method for photosensitive dry film, production method for patterned resist film, compound, photo-acid generator, and production method for n-organosulfonyloxy compound8 Sep 2022US 2022/0283500 A1Tokyo Ohka Kogyo.Co., Ltd.
Most cited
By later US patents
- Enantiomerically pure .beta.-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity53US 5,444,063 AEmory University · 1995
- Process for enantiomerically pure .beta.-L-1,3-oxathiolane nucleosides52US 5,248,776 AUniversity of Georgia Research Foundation, Inc. · 1993
- Stereoselective synthesis of nucleoside analogues using bicyclic intermediate22US 5,763,606 ABioChem Pharma Inc. · 1998
- Enantiomerically pure .beta.-D-dioxolane nucleosides with selective anti-hepatitis B virus activity21US 5,684,010 AEmory University · 1997
- Enantiomerically pure .beta.-d-dioxolane nucleosides15US 5,767,122 AEmory University · 1998